Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07260656 · ClinicalTrials.gov registry record · Early Phase 1
Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
A Early Phase 1 study, sponsored by Carilion Clinic.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
NCT07260656 is a Early Phase 1 study that is actively recruiting participants, run by Carilion Clinic. The registered enrollment target is 80 participants.
The verdict
NCT07260656, a Early Phase 1 study, is actively recruiting participants, sponsored by Carilion Clinic.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this research is to assess whether the use of a topical cream with an active ingredient can reduce the amount of foot pain experienced in participants who have been diagnosed with Diabetic Peripheral Neuropathy (DPN) with minimal side effects or discomfort from use.
Interventions
- DRUG Placebo
- DRUG Capsaicin Palmitate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-11-26 |
| Est. Completion | 2027-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07260656
The ClinicalTrials.gov registry entry for NCT07260656 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07260656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07260656 about?
NCT07260656 is a clinical study titled "Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain". The purpose of this research is to assess whether the use of a topical cream with an active ingredient can reduce the amount of foot pain experienced in participants who have been diagnosed with Diabetic Peripheral Neuropathy (DPN) with minimal side effects or discomfort from use.
What is the current status of trial NCT07260656?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2025-11-26. Estimated completion is 2027-11.
What interventions are being tested in trial NCT07260656?
The interventions under investigation include: Placebo (DRUG), Capsaicin Palmitate (DRUG).
Who is sponsoring clinical trial NCT07260656?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.